Merck & Co Inc - Company Profile
Powered by
All the data and insights you need on Merck & Co Inc in one report.
- Save hours of research time and resources with
our up-to-date Merck & Co Inc Strategy Report
- Understand Merck & Co Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Merck & Co Inc (Merck) is a biopharmaceutical company focused on the discovery, development, manufacturing and marketing of prescription medicines, biologic therapies, vaccines, and animal health products. It offers prescription products for therapy areas related to cardiovascular, cancer, immune disorders, infectious, respiratory, and diabetes. The company provides animal health products such as vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. The company and its subsidiaries operate in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.
Merck & Co Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
- | - |
Vaccine: | Zetia |
Influenza Virus Vaccine | Vytorin |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In March, the company entered into an agreement with IDEAYA Biosciences to appraise IDE161 in combination with KEYTRUDA. |
2024 | Acquisitions/Mergers/Takeovers | In March, the company completed the acquisition of Harpoon Therapeutics, Inc. |
2024 | Corporate Changes/Expansions | In March, the company opened its M Lab Collaboration Center in Shanghai, China. |
Competitor Comparison
Key Parameters | Merck & Co Inc | Johnson & Johnson | Pfizer Inc | AbbVie Inc | Sanofi |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | France |
City | Kenilworth | New Brunswick | New York | North Chicago | Paris |
State/Province | New Jersey | New Jersey | New York | Illinois | Ile-de-France |
No. of Employees | 72,000 | 131,900 | 88,000 | 50,000 | 87,994 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Robert M. Davis | Chairman; Chief Executive Officer; President | Executive Board | 2022 | 56 |
Caroline Litchfield | Chief Financial Officer; Executive Vice President | Senior Management | 2021 | 54 |
Michael Klobuchar | Executive Vice President; Chief Strategy Officer | Senior Management | 2021 | 47 |
Eliav Barr | Head - Global Clinical Development; Chief Medical Officer | Senior Management | 2022 | - |
Lisa LeCointe-Cephas | Chief Ethics and Compliance Officer; Senior Vice President | Senior Management | 2021 | 41 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward